⚖️ Weight Management · Apgujeong Hana Clinic
Mounjaro Weight Loss Seoul
English-friendly tirzepatide consultation with a board-certified endocrinologist in Gangnam—covering eligibility, diabetes and metabolic risk, weekly injection guidance, dose titration and long-term weight management.
✓
Tirzepatide eligibility review
✓
Weekly injection guidance
✓
English follow-up
Tirzepatide Dual-Signal Map
One medicine acting through GIP and GLP-1 pathways
Once weekly
GIP Receptor Pathway
Contributes to glucose-dependent metabolic signalling and forms one part of tirzepatide’s dual mechanism.
◎
Tirzepatide
Injection
Injection
GLP-1 Receptor Pathway
Influences appetite, fullness, glucose-dependent insulin response and digestive movement.
APPETITE
Hunger and food intake
FULLNESS
Meal satisfaction
GLUCOSE
Metabolic response
FOLLOW-UP
Dose and safety review
Brand indications differ by country. The consultation confirms whether Mounjaro, another tirzepatide product or a different weight-management treatment is currently appropriate under Korean prescribing requirements.
🩺
Prescription Assessment
Treatment begins only after an individual medical and safety review.
💉
Weekly Tirzepatide
The medicine is generally administered by subcutaneous injection once each week.
📈
Gradual Dose Increase
Treatment normally starts low and increases according to response and tolerance.
🔄
Long-Term Monitoring
Weight, appetite, glucose, side effects and maintenance needs are reviewed.
✓
Board-Certified Endocrinologist
✓
Mounjaro Prescription Assessment
✓
English Injection Guidance
✓
Apgujeong · Gangnam
Understanding Tirzepatide
Mounjaro contains tirzepatide, a dual GIP and GLP-1 receptor agonist.
Tirzepatide is a prescription injectable medicine that affects glucose-dependent metabolic signalling, appetite, fullness and food intake.
Mounjaro is widely recognised as a diabetes brand of tirzepatide. Tirzepatide is also used for chronic weight management under product names and indications that vary between countries.
At Apgujeong Hana Clinic, Dr. Shin Hyun-won reviews your weight, diabetes status, metabolic health, medicines and local prescribing requirements before recommending treatment.
🧬
Dual Receptor Activity
Tirzepatide activates both GIP and GLP-1 receptor pathways.
📅
Once-Weekly Treatment
The prescribed injection is generally taken on the same day each week.
🩸
Glucose Considerations
Diabetes medicines may need review as glucose levels and food intake change.
🥗
Combined Weight Plan
Medication is combined with nutrition, movement and long-term follow-up.
Mounjaro, Tirzepatide & Weight Management
The molecule may be the same while the brand indication can be different.
2️⃣
Mounjaro
Mounjaro is a tirzepatide brand primarily associated with treatment of Type 2 diabetes. Weight reduction may occur during treatment, but approved indications differ by market.
⚖️
Tirzepatide For Weight Management
Tirzepatide may be used under a weight-management indication for eligible patients with obesity or selected patients with overweight and related health conditions.
The page title does not guarantee that Mounjaro is the correct product for every weight-loss patient
The endocrinologist confirms the current Korean indication, product availability, eligibility and whether tirzepatide, semaglutide or another treatment is more appropriate.
Who May Be Considered?
Eligibility depends on metabolic risk, weight history and medical safety.
Obesity Treatment
Tirzepatide may be considered when BMI and overall health meet the relevant medical criteria.
Overweight With Health Risks
Hypertension, dyslipidaemia, sleep apnoea or other weight-related conditions may affect eligibility.
Type 2 Diabetes
Mounjaro may be considered for appropriate patients who need improved glucose management alongside diet and activity.
Prediabetes & Metabolic Risk
Glucose, insulin-related risk, fatty liver and cardiovascular markers may influence the treatment plan.
Repeated Weight Regain
Medical treatment may be discussed when previous lifestyle programs have not produced sustainable results.
International Patients
Consultation, prescription explanation, injection education and follow-up are available in English.
Before Starting Treatment
The first consultation evaluates benefit, risk and treatment alternatives.
🩺
Tirzepatide should not be selected from body weight alone.
The assessment reviews diabetes, cardiovascular and digestive health, current medicines, previous treatments, pregnancy plans and individual weight-management goals.
📋
Weight History
Previous weight changes, diets, injections, regain and current goals are reviewed.
🩸
Glucose & HbA1c
Diabetes, prediabetes and possible changes to glucose-lowering medicine are considered.
💊
Medicine Review
Include insulin, sulfonylureas, oral medicines, supplements and other weight treatments.
🧬
Thyroid Cancer History
Personal or family history of medullary thyroid carcinoma or MEN2 requires specific review.
🥣
Digestive & Pancreas History
Pancreatitis, gallbladder disease, severe gastroparesis and persistent digestive symptoms are discussed.
🤰
Pregnancy & Contraception
Pregnancy plans and oral contraceptive use should be discussed before initiation and dose changes.
How Tirzepatide Supports Weight Management
Treatment affects appetite and metabolic signalling while lifestyle care supports maintenance.
Reduced Appetite
Some patients experience less hunger, fewer cravings or less appetite-driven eating.
Earlier Fullness
Patients may feel satisfied with smaller meals or remain full for longer.
Glucose-Dependent Effects
Tirzepatide influences insulin and glucagon responses when glucose is elevated.
Slower Stomach Emptying
Digestive movement may slow, contributing to fullness and some gastrointestinal side effects.
Muscle-Preserving Plan
Protein intake and resistance activity remain important during weight reduction.
Long-Term Maintenance
Treatment planning includes plateaus, continuation decisions and possible weight regain.
Mounjaro Dose Titration
Tirzepatide normally starts at a low dose and increases gradually.
The sequence below reflects commonly available tirzepatide strengths. It is not a personal dosing schedule, and each increase requires medical guidance.
2.5 mg
Starting Dose
Commonly used to introduce treatment and assess early tolerance.
5 mg
First Treatment Dose
May follow the initial period when the medicine is tolerated.
7.5 mg
Intermediate Step
A titration strength used when further increase is clinically appropriate.
10 mg
Higher Dose
Response, glucose and digestive tolerance are reviewed before progression.
12.5 mg
Intermediate Step
May be used during gradual progression toward a higher maintenance dose.
15 mg
Maximum Adult Dose
Not every patient requires or tolerates the maximum labelled adult dose.
Dose increases are generally separated by at least four weeks
Escalation may be delayed when nausea, vomiting, constipation, inadequate food intake or dehydration remains significant. Never increase the dose independently.
Common Side Effects
Gastrointestinal symptoms are most common during initiation and dose increases.
Nausea
Smaller meals, avoiding overeating and slower dose progression may improve tolerance.
Vomiting
Repeated vomiting can cause dehydration and requires treatment review.
Diarrhea
Loose or frequent stool may occur, particularly during early treatment.
Constipation
Lower food intake, dehydration and slower digestive movement may contribute.
Abdominal Discomfort
Fullness, indigestion, bloating, belching or abdominal pain may occur.
Reduced Appetite
Appetite reduction should not lead to severe restriction, inadequate protein or dehydration.
Important Safety Information
Some medical histories require avoidance or additional monitoring.
📋 Tell The Doctor Before Treatment
✓
All prescriptions, supplements and other GLP-1 or tirzepatide products.
✓
Insulin or sulfonylurea use because hypoglycaemia risk may increase.
✓
Previous pancreatitis, gallstones or gallbladder disease.
✓
Kidney disease, dehydration or recurrent vomiting.
✓
Diabetic retinopathy, severe digestive disease or a planned procedure.
⚠️ Tirzepatide May Not Be Appropriate
!
With personal or family history of medullary thyroid carcinoma.
!
With Multiple Endocrine Neoplasia syndrome type 2.
!
With a serious allergy to tirzepatide or its ingredients.
!
During pregnancy or when treatment conflicts with pregnancy plans.
!
Together with another tirzepatide product unless specifically directed.
Tell your surgery or endoscopy team that you use tirzepatide
Tirzepatide may delay stomach emptying. The medical team needs this information before sedation, anaesthesia, gastroscopy, colonoscopy or surgery so individual fasting and medication instructions can be provided.
Seek Prompt Medical Advice
Severe or persistent symptoms require clinical assessment.
🤕
Severe Abdominal Pain
Persistent pain, especially when spreading toward the back or occurring with vomiting, requires urgent evaluation.
🤮
Repeated Vomiting
Contact the clinic when you cannot keep down fluids, food or essential medicines.
💧
Dehydration
Faintness, confusion, very low urine output or severe weakness requires prompt review.
🟡
Gallbladder Symptoms
Upper-right abdominal pain, fever, jaundice or pale stool may indicate a gallbladder problem.
🩸
Low Blood Sugar
Sweating, shaking, confusion or weakness is particularly important when insulin or sulfonylureas are used.
🚨
Allergic Reaction
Facial swelling, breathing difficulty or widespread rash requires emergency medical care.
More Than An Injection
Tirzepatide works within a complete medical weight-management plan.
Nutrition Strategy
Smaller balanced meals, adequate protein, fibre and hydration support tolerance and muscle health.
Strength Preservation
Resistance activity helps protect muscle and function during weight reduction.
Regular Movement
Walking and aerobic activity are progressed according to fitness and medical conditions.
Sleep & Recovery
Poor sleep and possible sleep apnoea may affect appetite, energy and metabolic health.
Health Monitoring
Weight, waist, glucose, blood pressure, cholesterol and other markers may be followed.
Maintenance Planning
The plan addresses plateaus, continuation, treatment changes and possible weight regain.
Your Mounjaro Clinic Visit
How consultation, prescription and monitoring work.
1
Book In English
Contact the clinic and mention that you need a Mounjaro or tirzepatide weight-management consultation.
2
Medical Assessment
Review weight, BMI, glucose, medicines, contraindications and relevant medical conditions.
3
Prescription & Training
When appropriate and available, receive product, dose, storage and injection instructions in English.
4
Follow-Up & Titration
Review appetite, weight, glucose, side effects, dose progression and maintenance planning.
Apgujeong, Gangnam
Mounjaro and tirzepatide consultation in English.
Apgujeong Hana Clinic provides specialist-led weight and metabolic care for expats, residents and international patients in Seoul.
📍
328 Apgujeong-ro, Gangnam-gu, Seoul, KFC Building 3F
🕘
Monday–Friday 09:00–19:00
🗓️
Saturday 09:00–13:00
📞
02) 3443-7550
⚕️
Dr. Shin Hyun-won
Board-certified endocrinologist and internal-medicine specialist with more than 20 years of experience in diabetes, hormones, obesity and metabolic medicine.
FAQ
Mounjaro weight-loss questions, answered.
Product indication, availability and prescription requirements can change. Current options are confirmed during your consultation.
Apgujeong Hana Clinic offers medical assessment for Mounjaro, tirzepatide and other GLP-1-based treatments. Prescription depends on your diagnosis, eligibility, safety, current Korean requirements and product availability.
The approved indication for the Mounjaro brand varies by country. Tirzepatide is also marketed under weight-management indications in some markets. Your doctor will confirm the appropriate locally authorised product and indication.
Mounjaro contains tirzepatide and activates both GIP and GLP-1 receptor pathways. Wegovy contains semaglutide and acts through the GLP-1 receptor pathway. Suitability depends on medical history, indication, tolerance and availability.
Mounjaro is generally injected under the skin once weekly. Use the exact day, dose and missed-dose instructions provided for your prescribed product.
No. Tirzepatide normally begins at a low starting dose and increases gradually. Beginning at a high dose can substantially increase gastrointestinal side effects and dehydration risk.
Results vary according to diagnosis, dose, treatment duration, starting weight, eating pattern, activity, medical conditions and tolerance. The clinic does not guarantee a fixed amount or timeline.
The risk is higher when tirzepatide is combined with insulin or medicines such as sulfonylureas. Diabetes treatment may need adjustment and glucose monitoring.
Weight-loss treatment with tirzepatide is not used during pregnancy. Tell the doctor about pregnancy, breastfeeding, fertility treatment and pregnancy plans before starting.
Message WhatsApp +82 10-2950-7551, call 02) 3443-7550 or use Naver Booking. Include your age, height, weight, diabetes status, current medicines and relevant medical conditions.
Related Weight Management Services
Explore related injection and metabolic-health pages.
Considering Mounjaro or tirzepatide for weight management?
Book an English-friendly eligibility and safety consultation with a board-certified endocrinologist at Apgujeong Hana Clinic in Gangnam.